Ophthalmic Portfolios

ImprimisRx® formulates compounded medications typically prescribed by physicians in the ophthalmic industry, and is one of the largest compounding pharmacies servicing both optometry and ophthalmology. ImprimisRx® is committed to delivering high-quality formulations that are required to meet applicable U.S. Pharmacopeia (USP) or current guidelines. Click here to learn more about our quality standards.

Dropless Cataract Surgery

Dropless® Injectable Formulation*

  • Tri-Moxi® (triamcinolone and moxifloxacin hydrochloride)

Less Drops Combination Drop Therapy

Combination Topical Drop Formulations*

  • Pred-Gati® (prednisolone acetate, gatifloxacin)*
  • Pred-Brom® (prednisolone acetate and bromfenac)*
  • Pred-Gati-Brom®(prednisolone acetate, gatifloxacin and bromfenac)*
  • Pred-Nepaf® (prednisolone, nepafenac)* (COMING SOON!)
  • Pred-Moxi® (prednisolone, moxifloxacin)*
  • Pred-Moxi-Nepaf (prednisolone, moxifloxacin, nepafenac)*

Non-invasive sublingual conscious sedation provides consistent predictable dosing.

Oral Sedation Formulation*

  • MKO Melt® (midazolam, ketamine and ondansetron)*

 

 Topical Formulations*

 

 
Patients may need to take more than one eye drop product pursuant to multiple dosing regimens, as directed by his or her prescriber, in order for the active ingredients to remain effective throughout the day.

Preservative-Free Topical Formulations*

 

Topical Formulations Typically Prescribed by Physicians in the Ophthalmic Market

Injectable Formulations Typically Prescribed by Physicians in the Ophthalmic Market